September 2022
First study author, Joel M. Gelfand, MD, MSCE, and the investigators discovered that apremilast (brand name Otezla), which has helped psoriasis patients achieve clearer skin and ease the symptoms of their psoriatic arthritis, could also help people with psoriasis shed unhealthy body fat and therefore improve cardiovascular health, a well-known vulnerability for those with psoriasis.
Read the article in JAMA Dermatology.